UNDERWRITING AGREEMENTUnderwriting Agreement • July 15th, 2019 • Castle Biosciences Inc • Services-medical laboratories • New York
CASTLE BIOSCIENCES, INC. SIXTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT July 12, 2019Rights Agreement • July 15th, 2019 • Castle Biosciences Inc • Services-medical laboratories • Delaware
This Sixth Amended and Restated Investors’ Rights Agreement (this “Agreement”) is dated as of July 12, 2019, and is between Castle Biosciences, Inc., a Delaware corporation (the “Company”), the persons and entities listed on Exhibit A hereto (each, an “Investor” and collectively, the “Investors”), and SH Castle Biosciences, LLC (“Stonebridge-Highland” and also referred to as an “Investor” for purposes of Section 2 of this Agreement, and only a party to this Agreement for purposes of Section 2 of this Agreement and the applicable provisions in Sections 1 and 7.1 of this Agreement in connection therewith). This Agreement amends and restates that certain Fifth Amended and Restated Investors’ Rights Agreement dated July 15, 2015 (the “Prior Agreement”), by and between the Company and certain of the Investors. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
